Broglie M G
Z Gesamte Inn Med. 1990 Dec 1;45(23):717-8.
After performance of the phases I to III of the drug test which is carried out in clinics and special institutions into the phase IV, the ambulatory test, mainly the physician with own practice is included. This test is performed either as a controlled study with clearly outlined test aim and methodology or as open study in which physician and patient known which medicaments are used. Before the physician participates in a clinical study he should for himself carry out a preliminary test. Thereby he should carefully consider the proportionality of the necessity of the testing against possible dangers for the individual and also the feasibility of the test in his practice with its patients. An important prerequisite is the presence of a test plan, whereby the information and the consent of the patients or test person is decisive for the permissibility of the test. The producer of the test preparation takes the total responsibility for the clinical test including the liability.
在药品试验的第一至三阶段在诊所和特殊机构进行之后进入第四阶段,即门诊试验,主要纳入有自己诊所的医生。该试验要么作为具有明确界定的试验目的和方法的对照研究进行,要么作为医生和患者都知道使用了哪些药物的开放研究进行。在医生参与临床研究之前,他应该自己先进行初步试验。在此过程中,他应该仔细考虑试验必要性与对个体可能风险之间的比例关系,以及该试验在其诊所患者中的可行性。一个重要的前提是要有试验计划,患者或试验对象的信息和同意对于试验的可允许性具有决定性作用。试验制剂的生产商对临床试验承担全部责任,包括法律责任。